Principal Scientist, Bioprocess R&D
Pfizer
Carrie Simms, PhD is a Principal Scientist, Bioprocess R&D, at Pfizer. She joined Pfizer 2.5 years ago and currently a member of the Nucleic Acids Medicines technology development team in Bioprocess R&D. Completed a PhD in Molecular Biology and Biochemistry at Simon Fraser University in Canada followed by post-doctoral training in RNA biochemistry, studying the effects of RNA damage on translation. Additional industry experience at Fimbrion therapeutics, a St Louis biotech focused on development of alternatives to traditional antibiotics.